Date | Price to Book Ratio (P/B) | Dividend Yield | Free Cash Flow Yield | Price to Earnings Ratio (P/E) |
---|
CEO | Mr. Simon Thorsten Wiebusch |
IPO Date | Jan. 8, 2010 |
Location | India |
Headquarters | Bayer House |
Employees | 1,317 |
Sector | Consumer Staples |
Industries |
Bayer CropScience Limited engages in the manufacture, sale, and distribution of insecticides, fungicides, herbicides, and various other agrochemical products and corn seeds in India, Germany, Bangladesh, and internationally. It provides medicines primarily in the therapeutic areas of cardiology, gynecology, diabetes, oncology, and ophthalmology; and diagnostic imaging equipment and other contrast agents, including computed tomography, X-Ray, and magnetic resonance imaging devices. In addition, the company offers consumer health products that are used as a daily health solution to treat minor illnesses, as well as sells and distributes hybrid seeds, such as corn and paddy. Further, it provides digital farming products comprising FarmRiseTM and digital prediction systems that integrate data from farm equipment, satellites, field sensors, irrigation systems, drones, and other input sources and then analyze that data to allow farmers to make decisions through data science and predictive analytics. The company also exports its products. Bayer CropScience Limited was incorporated in 1958 and is based in Thane, India.
Past 5 years
USD 64.30
USD 15.72
USD 40.01
USD 468.92
USD 21.21
StockViz Staff
January 15, 2025
Any question? Send us an email